Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
The closing price of Acrivon Therapeutics Inc (NASDAQ: ACRV) was $1.93 for the day, down -34.58% from the previous closing price of $2.95. In other words, the price has decreased by -$34.58 from its previous closing price. On the day, 42.4 million shares were traded. ACRV stock price reached its highest trading level at $2.8 during the session, while it also had its lowest trading level at $1.89.
Ratios:
Our analysis of ACRV’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 8.75 and its Current Ratio is at 8.75. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
Ladenburg Thalmann Upgraded its Neutral to Buy on September 16, 2024, while the target price for the stock was maintained at $16.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Apr 30 ’25 when PERCEPTIVE ADVISORS LLC sold 437,881 shares for $1.41 per share. The transaction valued at 617,412 led to the insider holds 3,403,025 shares of the business.
PERCEPTIVE ADVISORS LLC sold 298,886 shares of ACRV for $400,507 on May 01 ’25. The 10% Owner now owns 3,104,139 shares after completing the transaction at $1.34 per share. On Apr 25 ’25, another insider, PERCEPTIVE ADVISORS LLC, who serves as the 10% Owner of the company, sold 1,054,669 shares for $1.95 each. As a result, the insider received 2,056,605 and left with 4,306,189 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ACRV now has a Market Capitalization of 60901392 and an Enterprise Value of -65363608.
Stock Price History:
The Beta on a monthly basis for ACRV is 1.73, which has changed by -0.46069467 over the last 52 weeks, in comparison to a change of 0.1877265 over the same period for the S&P500. Over the past 52 weeks, ACRV has reached a high of $8.00, while it has fallen to a 52-week low of $1.05. The 50-Day Moving Average of the stock is -16.45%, while the 200-Day Moving Average is calculated to be 13.00%.
Shares Statistics:
ACRV traded an average of 783.92K shares per day over the past three months and 878130 shares per day over the past ten days. A total of 31.55M shares are outstanding, with a floating share count of 22.27M. Insiders hold about 29.43% of the company’s shares, while institutions hold 48.08% stake in the company. Shares short for ACRV as of 1765756800 were 5121709 with a Short Ratio of 6.53, compared to 1763078400 on 3702932. Therefore, it implies a Short% of Shares Outstanding of 5121709 and a Short% of Float of 42.870000000000005.
Earnings Estimates
. The current market rating for Acrivon Therapeutics Inc (ACRV) reflects the collective analysis of 7.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$0.5, with high estimates of -$0.4 and low estimates of -$0.56.
Analysts are recommending an EPS of between -$1.64 and -$2.05 for the fiscal current year, implying an average EPS of -$1.97. EPS for the following year is -$1.91, with 7.0 analysts recommending between -$1.43 and -$2.65.
